Ligand validation:5VJF

13P: 1,3-DIHYDROXYACETONEPHOSPHATE

13P is a Ligand Of Interest in 5VJF designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5VJF_13P_B_404	92%	33%	0.084	0.974	2.02	0.66	4	-	0	0	100%	1
5VJF_13P_A_405	87%	26%	0.097	0.97	2.32	0.73	4	-	0	0	100%	1
5UD2_13P_A_404	72%	58%	0.124	0.947	0.52	1.08	-	-	1	0	100%	1
5UCK_13P_B_404	69%	60%	0.121	0.934	0.58	0.96	-	-	2	0	100%	0.7
5UD0_13P_B_405	63%	38%	0.145	0.939	0.64	1.76	-	4	5	0	100%	0.87
5UCP_13P_B_405	60%	42%	0.133	0.917	0.6	1.64	-	4	3	0	100%	0.8
5UCZ_13P_B_404	56%	58%	0.183	0.955	0.52	1.09	-	-	0	0	100%	0.4
2QJI_13P_M_501	100%	27%	0.031	0.991	1.54	1.38	1	2	2	0	100%	0.9
2R4J_13P_B_816	100%	1%	0.043	0.988	4.34	3.7	6	4	3	0	100%	1
5KTN_13P_A_402	99%	21%	0.052	0.991	2.39	0.95	1	-	0	0	100%	1
3MHG_13P_C_3003	98%	27%	0.063	0.982	2.15	0.84	2	-	1	0	100%	0.9
3DFS_13P_D_3004	97%	56%	0.066	0.983	0.72	0.99	-	1	1	0	100%	0.9

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.